Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (CVS)
NYSE:CVS
CVS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$43.56 - $72.51
Previous CloseN/A
Volume5.40M
Average Volume (3M)8.04M
Market Cap
$82.29B
Enterprise Value$156.28B
Total Cash (Recent Filing)$14.22B
Total Debt (Recent Filing)$82.72B
Price to Earnings (P/E)18.1
Beta0.52
Next Earnings
Oct 29, 2025EPS Estimate
1.39Last Dividend Ex-Date
Jul 22, 2025Dividend Yield4.1%
Share Statistics
EPS (TTM)1.81
Shares Outstanding1,268,326,400
10 Day Avg. Volume10,732,147
30 Day Avg. Volume8,036,823
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.90
Enterprise Value/Revenue0.40
Enterprise Value/Gross Profit2.92
Enterprise Value/Ebitda12.01
Forecast
1Y Price Target
$81.73Price Target Upside25.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
Bulls Say, Bears Say
Bulls Say
Contract WinsCVS Caremark wins contract from OptumRx, providing outpatient prescription drug benefits for approximately 587K members enrolled in Basic or Medicare HMO and PPO plans.
Financial PerformanceResults continue to be buoyed by strength in Caremark and PCW which are important to overall growth and sources of potential upside.
Market PositionCVS is capturing unique tailwinds in the retail pharmacy market, driven by industry consolidation and CVS’ position as an integrated PBM, mail/specialty pharmacy, and retail pharmacy.
Bears Say
Operating IncomeThere is an expectation of a decline in adjusted operating income for PCW in the second half of the year.
Segment ChallengesThe PDR in the group MA segment was not a complete surprise given earlier commentary about an elevated trend in the segment, and likely requires a few years to fix.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $43.56 and its highest was $72.51 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $82.29B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Oct 29, 2025 which is in 77 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Jul 31, 2025. The company reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.458 by $0.352.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 4.1%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.39.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,268,326,400 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $1.81 in its last earnings report, beating expectations of $1.458. Following the earnings report the stock price went down -0.321%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
CVS Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$81.73 (25.97% Upside)
$81.73 (25.97% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 73%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 700.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $100.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 3.7%
Last 30 Days ▲ 3.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.81%
12-Months-Change
Fundamentals
Return on Equity
5.95%
Trailing 12-Months
Asset Growth
2.32%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Company Deck
CVS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong financial performance and growth in key business segments like pharmacy services and retail. However, challenges remain in the health care delivery segment, particularly with Oak Street Health, and the Group Medicare Advantage business faced cost pressures. Despite these challenges, CVS Health's positive financial outlook and growth initiatives provide a balanced view.View all CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$81.73
▲(25.97% Upside)
Technical Analysis
Ownership Overview
0.72% Insiders
32.54% Mutual Funds
1.08% Other Institutional Investors
45.04% Public Companies and Individual Investors